Zum Hauptinhalt springen

Amphetamine

08. Mai 2025 | Amphetamine

Impact of recent methamphetamine use on treatment outcomes among individuals initiating medications for opioid use disorders in rural treatment settings: a 1-year retrospective cohort study.

Impact of recent methamphetamine use on treatment outcomes among individuals initiating medications for opioid use disorders in rural treatment settings: a 1-year retrospective cohort study. Kenefick LA, Khairy L, Hall L, Kwon K, Limberg N, K…

08. Mai 2025 | Amphetamine

Amphetamines: a current epidemic.

Amphetamines: a current epidemic. Miller N. Front Psychiatry. 2025 Mar 25;16:1460341. doi: 10.3389/fpsyt.2025.1460341. PMID: 40201060; PMCID: PMC11975895. https://pmc.ncbi.nlm.nih.gov/articles/PMC11975895/

08. Mai 2025 | Amphetamine

Methamphetamine use and associated factors among people who inject drugs in Iran 2020.

Methamphetamine use and associated factors among people who inject drugs in Iran 2020. Mansoori Y, Mehmandoost S, Khezri M, Mirzazadeh A, Haghdoost AA, Tavakoli F, Nasiri N, Sharifi M, Rashidi H, Iranpour A, Shokoohi M, Ghalekhani N, Pedarzad…

08. Mai 2025 | Amphetamine

Impact of recent stimulant use on treatment outcomes amongst individuals initiating medications for opioid use disorders: Secondary analysis of a multisite randomized controlled trial.

Impact of recent stimulant use on treatment outcomes amongst individuals initiating medications for opioid use disorders: Secondary analysis of a multisite randomized controlled trial. Coles C, Batts C, Bae J, León G, Schmidt A, McPherson SM…

08. Mai 2025 | Amphetamine

The impact of psychostimulant use on office based buprenorphine treatment retention.

The impact of psychostimulant use on office based buprenorphine treatment retention. Edgerton R, Rebeiro P, MacMaster S, Bell L, Patel P, Ginn L, Beach K, Shah V, Cooper RL. Harm Reduct J. 2025 Apr 12;22(1):51. doi: 10.1186/s12954-025-…

08. Februar 2025 | Amphetamine

Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo-controlled trial.

Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo-controlled trial. Ezard N, Clifford B, Siefried KJ, Ali R, Dunlop A, McKetin R, et al. Addiction.&n…

05. Januar 2025 | Amphetamine

Acute effects of R-MDMA, S-MDMA, and racemic MDMA in a randomized double-blind cross-over trial in healthy participants.

Acute effects of R-MDMA, S-MDMA, and racemic MDMA in a randomized double-blind cross-over trial in healthy participants. Straumann I, Avedisian I, Klaiber A, Varghese N, Eckert A, Rudin D, Luethi D, Liechti ME. Neuropsychopharmacology. 2024…

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten